First year PSA kinetics and nadirs after prostate cancer radiotherapy are predictive of overall survival

被引：0
|
作者：
Cheung, R [1 ]
Tucker, S [1 ]
Kuban, D [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.345
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1091
引用
收藏
页码：S199 / S200
页数：2
相关论文
共 50 条
  • [31] The management of PSA failure after radical radiotherapy for localized prostate cancer
    Parker, CC
    Dearnaley, DP
    RADIOTHERAPY AND ONCOLOGY, 1998, 49 (02) : 103 - 110
  • [32] PSA AFTER DEFINITIVE RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    GOAD, JR
    CHANG, SJ
    OHORI, M
    SCARDINO, PT
    UROLOGIC CLINICS OF NORTH AMERICA, 1993, 20 (04) : 727 - 736
  • [33] PSA Kinetics and Outcomes after Magnetic Resonance Image-Guided Stereotactic Body Radiotherapy for Prostate Cancer
    Ugurluer, G.
    Mustafayev, T. Z.
    Atalar, B.
    Gungor, G.
    Sengoz, M.
    Abacioglu, M. U.
    Tuna, M. B.
    Kural, A. R.
    Ozyar, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E248 - E249
  • [34] PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate
    Espana, Sofia
    de Olza, Maria Ochoa
    Sala, Nuria
    Piulats, Josep Maria
    Ferrandiz, Ulises
    Etxaniz, Olatz
    Heras, Lucia
    Buisan, Oscar
    Pardo, Juan Carlos
    Suarez, Jose F.
    Barretina, Pilar
    Comet, Josep
    del Muro, Xavier Garcia
    Sumoy, Lauro
    Font, Albert
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 10251 - 10260
  • [35] Long-term durability of PSA failure-free survival after radiotherapy for localized prostate cancer
    Yock, TI
    Zietman, AL
    Shipley, WU
    Thakral, HK
    Coen, JJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02): : 420 - 426
  • [36] Public health impact of PSA doubling time after radical prostatectomy on prostate cancer specific and overall survival.
    Freedland, S. J.
    Humphreys, E. B.
    Mangold, L. A.
    Eisenberger, M.
    George, D. J.
    Partin, A. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 233S - 233S
  • [37] Role of statins and PSA nadir after androgen-deprivation therapy in overall survival of patients with metastatic prostate cancer
    Siddiqui, Salma
    Durbin-Johnson, Blythe P.
    Yap, Stanley A.
    White, Ralph W. deVere
    Ghosh, Paramita M.
    CANCER RESEARCH, 2019, 79 (13)
  • [38] Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer
    D'Amico, AV
    Keshaviah, A
    Manola, J
    Cote, K
    Loffredo, M
    Iskrzytzky, O
    Renshaw, AA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (03): : 581 - 587
  • [39] Analysis of PSA kinetics after HDR brachytherapy in prostate cancer patients
    Burchardt, W.
    Skowronek, J.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S948 - S948
  • [40] Accuracy of life, tables in predicting overall survival in candidates for radiotherapy for prostate cancer
    Walz, Jochen
    Gallina, Andrea
    Hutterer, Georg
    Perrotte, Paul
    Shariat, Shahrokh F.
    Graefen, Markus
    McCormack, Michael
    Benard, Francois
    Valiquette, Luc
    Saad, Fred
    Karakiewicz, Pierre I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (01): : 88 - 94
12345